Purpose This systematic review with network meta-analysis compared the efficacy and safety of currently licensed second-line treatments in patients with late stage non-small cell lung cancer (NSCLC).
Ferroptosis, a recently discovered form of regulated cell death, has been closely linked to tumor progression. However, the underlying mechanism of ferroptosis in non-small cell lung cancer (NSCLC) re
Real-world study of PD-L1 testing patterns and treatment distribution in patients with metastatic Non-Small Cell Lung Cancer in Israel Table A1 : Attrition table for the cohort <